Feds Push For 1st Circ. To Reopen FCA Suit Against Pfizer
While the U.S. government did not intervene in the qui tam action, it said it had filed the amicus brief because it had a major and ongoing interest in ensuring the FCA could be deployed in qui tam suits centered on kickback claims.
“[A]n entity that knowingly causes the submission of...
To view the full article, register now.